Cetera Investment Advisers’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.82M Buy
25,715
+429
+2% +$61.1K ﹤0.01% 1962
2025
Q4
$4.21M Buy
25,286
+6,928
+38% +$1.16M ﹤0.01% 1589
2025
Q3
$3.59M Buy
18,358
+9,227
+101% +$1.52M ﹤0.01% 1679
2025
Q2
$826K Buy
9,131
+5,712
+167% +$451K ﹤0.01% 2546
2025
Q1
$204K Sell
3,419
-54
-2% -$5K ﹤0.01% 3585
2024
Q4
$460K Buy
+3,473
New +$326K ﹤0.01% 2749

Other funds holding ALAB

Cetera Investment Advisers's ALAB Position: Q1 2026 in Review

Cetera Investment Advisers increased its Astera Labs (ALAB) stake by 1.7% in Q1 2026, buying an estimated $61.1K and bringing the position to 25,715 shares worth $2.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1962.

Cetera Investment Advisers first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.21M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Cetera Investment Advisers held 25,715 shares of Astera Labs worth $2.82M as of Q1 2026.
  • Cetera Investment Advisers bought 429 Astera Labs shares in Q1 2026, an estimated $61.1K.
  • Astera Labs made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #1962 holding.
  • Cetera Investment Advisers first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • Cetera Investment Advisers's Astera Labs position peaked at $4.21M in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.